Marinomed Biotech AG | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 10/11/2024 at 12:53, 23 days ago

Marinomed Biotech AG entame des négociations pour la vente du portefeuille de Carragelose

Marinomed Biotech AG Transaction D'actifs Portefeuille De Carragelose Négociations Contractuelles Processus De Restructuration
BRIEF

published on 10/11/2024 at 12:53, 23 days ago

Marinomed Biotech AG Enters Negotiations for Carragelose Portfolio Sale

Asset Deal Marinomed Biotech AG Restructuring Process Carragelose Portfolio Contract Negotiations
PRESS RELEASE

published on 10/11/2024 at 12:48, 23 days ago

EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
Marinomed Biotech AG initiates contract negotiations for the sale of Carragelose portfolio, aiming for long-term strategy through strategic company decision

Strategic Decision Sale Marinomed Biotech AG Carragelose Portfolio Contract Negotiations
BRIEF

published on 10/08/2024 at 07:50, 26 days 5 hours ago

Marinomed Biotech AG annonce des résultats d'essais positifs pour les gouttes ophtalmiques au tacrolimus

Essai Clinique Marinosolv Biodisponibilité Tacrosolv Conjonctivite Allergique
BRIEF

published on 10/08/2024 at 07:50, 26 days 5 hours ago

Marinomed Biotech AG Reports Positive Trial Results for Tacrolimus Eye Drops

Clinical Trial Bioavailability Marinosolv Tacrosolv Allergic Conjunctivitis
PRESS RELEASE

published on 10/08/2024 at 07:45, 26 days 5 hours ago

Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Marinomed Biotech AG publishes study results on Tacrolimus eye drops, showing significant alleviation of allergic eye inflammation. Potential treatment for inflammatory eye diseases

Marinomed Biotech AG Study Results Ocular Surface Tacrolimus Eye Drops Allergic Eye Inflammation
BRIEF

published on 09/24/2024 at 07:50, 1 month 9 days ago

Marinomed Biotech AG annonce des résultats cliniques positifs pour ses gouttes oculaires uniques à base de carraghénane

Marinomed Biotech AG Résultats Cliniques Carraghénose Gouttes Pour Les Yeux Syndrome De L'œil Sec
BRIEF

published on 09/24/2024 at 07:50, 1 month 9 days ago

Marinomed Biotech AG Reports Positive Clinical Results for Unique Carragelose Eye Drops

Marinomed Biotech AG Carragelose Clinical Results Eye Drops Dry Eye Syndrome
PRESS RELEASE

published on 09/24/2024 at 07:45, 1 month 9 days ago

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate

Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops
BRIEF

published on 09/18/2024 at 17:26, 1 month 14 days ago

Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights

Investors Capital Increase Marinomed Biotech AG Subscription Rights Issue Price

1 2 ... 8

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 31 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 18 hours 1 minute ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 6 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 46 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE